SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-15-000372
Filing Date
2015-02-27
Accepted
2015-02-27 09:14:12
Documents
10
Period of Report
2014-11-30

Document Format Files

Seq Description Document Type Size
1 10-K s100792_10k.htm 10-K 134427
2 EXHIBIT 31.1 s100792_ex31-1.htm EX-31.1 9162
3 EXHIBIT 31.2 s100792_ex31-2.htm EX-31.2 9310
4 EXHIBIT 32 s100792_ex32.htm EX-32 5212
  Complete submission text file 0001615774-15-000372.txt   2142033

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cnlm-20141130.xml EX-101.INS 210346
6 XBRL SCHEMA FILE cnlm-20141130.xsd EX-101.SCH 26662
7 XBRL CALCULATION FILE cnlm-20141130_cal.xml EX-101.CAL 16344
8 XBRL DEFINITION FILE cnlm-20141130_def.xml EX-101.DEF 132559
9 XBRL LABEL FILE cnlm-20141130_lab.xml EX-101.LAB 146726
10 XBRL PRESENTATION FILE cnlm-20141130_pre.xml EX-101.PRE 158048
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500
CB Pharma Acquisition Corp. (Filer) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 001-36757 | Film No.: 15655183
SIC: 6770 Blank Checks